AAAAAA

   
Results: 1-15 |
Results: 15
HUMAN KALLIKREIN-2 (HK2) AND PROSTATE-SPECIFIC ANTIGEN (PSA) - 2 CLOSELY-RELATED, BUT DISTINCT, KALLIKREINS IN THE PROSTATE
Authors: RITTENHOUSE HG FINLAY JA MIKOLAJCZYK SD PARTIN AW
Citation: Hg. Rittenhouse et al., HUMAN KALLIKREIN-2 (HK2) AND PROSTATE-SPECIFIC ANTIGEN (PSA) - 2 CLOSELY-RELATED, BUT DISTINCT, KALLIKREINS IN THE PROSTATE, Critical reviews in clinical laboratory sciences, 35(4), 1998, pp. 275-368
HUMAN GLANDULAR KALLIKREIN, HK2, SHOWS ARGININE-RESTRICTED SPECIFICITY AND FORMS COMPLEXES WITH PLASMA PROTEASE INHIBITORS
Authors: MIKOLAJCZYK SD MILLAR LS KUMAR A SAEDI MS
Citation: Sd. Mikolajczyk et al., HUMAN GLANDULAR KALLIKREIN, HK2, SHOWS ARGININE-RESTRICTED SPECIFICITY AND FORMS COMPLEXES WITH PLASMA PROTEASE INHIBITORS, The Prostate, 34(1), 1998, pp. 44-50
DETECTION OF HUMAN GLANDULAR KALLIKREIN, HK2, AS ITS PRECURSOR FORM AND IN COMPLEX WITH PROTEASE INHIBITORS IN PROSTATE CARCINOMA SERUM
Authors: GRAUER LS FINLAY JA MIKOLAJCZYK SD PUSATERI KD WOLFERT RL
Citation: Ls. Grauer et al., DETECTION OF HUMAN GLANDULAR KALLIKREIN, HK2, AS ITS PRECURSOR FORM AND IN COMPLEX WITH PROTEASE INHIBITORS IN PROSTATE CARCINOMA SERUM, Journal of andrology, 19(4), 1998, pp. 407-411
DEVELOPMENT OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN GLANDULAR KALLIKREIN (HK2) - DEVELOPMENT OF A DUAL ANTIBODY IMMUNOASSAY FOR HK2 WITH NEGLIGIBLE PROSTATE-SPECIFIC ANTIGEN CROSS-REACTIVITY
Authors: FINLAY JA EVANS CL DAY JR PAYNE JK MIKOLAJCZYK SD MILLAR LS KUUSREICHEL K WOLFERT RL RITTENHOUSE HG
Citation: Ja. Finlay et al., DEVELOPMENT OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN GLANDULAR KALLIKREIN (HK2) - DEVELOPMENT OF A DUAL ANTIBODY IMMUNOASSAY FOR HK2 WITH NEGLIGIBLE PROSTATE-SPECIFIC ANTIGEN CROSS-REACTIVITY, Urology, 51(5), 1998, pp. 804-809
THE PRECURSOR FORM OF THE HUMAN KALLIKREIN-2, A KALLIKREIN HOMOLOGOUSTO PROSTATE-SPECIFIC ANTIGEN, IS PRESENT IN HUMAN SERA AND IS INCREASED IN PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA
Authors: SAEDI MS HILL TM KUUSREICHEL K KUMAR A PAYNE J MIKOLAJCZYK SD WOLFERT RL RITTENHOUSE HG
Citation: Ms. Saedi et al., THE PRECURSOR FORM OF THE HUMAN KALLIKREIN-2, A KALLIKREIN HOMOLOGOUSTO PROSTATE-SPECIFIC ANTIGEN, IS PRESENT IN HUMAN SERA AND IS INCREASED IN PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA, Clinical chemistry, 44(10), 1998, pp. 2115-2119
A PRECURSOR FORM OF PSA (PPSA) IS A COMPONENT OF THE FREE PSA IN PROSTATE-CANCER SERUM
Authors: MIKOLAJCZYK SD GRAUER LS MILLAR LS HILL TM KUMAR A RITTENHOUSE HG WOLFERT RL SAEDI MS
Citation: Sd. Mikolajczyk et al., A PRECURSOR FORM OF PSA (PPSA) IS A COMPONENT OF THE FREE PSA IN PROSTATE-CANCER SERUM, Urology, 50(5), 1997, pp. 710-714
DETECTION OF A PROSTATE-SPECIFIC PROTEIN, HUMAN GLANDULAR KALLIKREIN (HK2), IN SERA OF PATIENTS WITH ELEVATED PROSTATE-SPECIFIC ANTIGEN LEVELS
Authors: CHARLESWORTH MC YOUNG CYF KLEE GG SAEDI MS MIKOLAJCZYK SD FINLAY JA TINDALL DJ
Citation: Mc. Charlesworth et al., DETECTION OF A PROSTATE-SPECIFIC PROTEIN, HUMAN GLANDULAR KALLIKREIN (HK2), IN SERA OF PATIENTS WITH ELEVATED PROSTATE-SPECIFIC ANTIGEN LEVELS, Urology, 49(3), 1997, pp. 487-493
ALA217 IS IMPORTANT FOR THE CATALYTIC FUNCTION AND AUTOACTIVATION OF PROSTATE-SPECIFIC HUMAN KALLIKREIN-2
Authors: MIKOLAJCZYK SD MILLAR LS MARKER KM GRAUER LS GOEL A CASS MMJ KUMAR A SAEDI MS
Citation: Sd. Mikolajczyk et al., ALA217 IS IMPORTANT FOR THE CATALYTIC FUNCTION AND AUTOACTIVATION OF PROSTATE-SPECIFIC HUMAN KALLIKREIN-2, European journal of biochemistry, 246(2), 1997, pp. 440-446
EXPRESSION OF PRO FORM OF PROSTATE-SPECIFIC ANTIGEN BY MAMMALIAN-CELLS AND ITS CONVERSION TO MATURE, ACTIVE FORM BY HUMAN KALLIKREIN-2
Authors: KUMAR A MIKOLAJCZYK SD GOEL AS MILLAR LS SAEDI MS
Citation: A. Kumar et al., EXPRESSION OF PRO FORM OF PROSTATE-SPECIFIC ANTIGEN BY MAMMALIAN-CELLS AND ITS CONVERSION TO MATURE, ACTIVE FORM BY HUMAN KALLIKREIN-2, Cancer research, 57(15), 1997, pp. 3111-3114
DEXTRAN MODIFICATION OF A FAB'-BETA-LACTAMASE CONJUGATE MODULATED BY VARIABLE PRETREATMENT OF FAB' WITH AMINE-BLOCKING REAGENTS
Authors: MIKOLAJCZYK SD MEYER DL FAGNANI R HAGAN MS LAW KL STARLING JJ
Citation: Sd. Mikolajczyk et al., DEXTRAN MODIFICATION OF A FAB'-BETA-LACTAMASE CONJUGATE MODULATED BY VARIABLE PRETREATMENT OF FAB' WITH AMINE-BLOCKING REAGENTS, Bioconjugate chemistry, 7(1), 1996, pp. 150-158
EXPRESSION OF THE SERINE-PROTEASE, HUMAN PROSTATE-SPECIFIC GLANDULAR KALLIKREIN (HK2), IN MAMMALIAN-CELLS
Authors: SAEDI MS GOEL AS HILL TM MIKOLAJCZYK SD KUUSREICHEL K KUMAR A
Citation: Ms. Saedi et al., EXPRESSION OF THE SERINE-PROTEASE, HUMAN PROSTATE-SPECIFIC GLANDULAR KALLIKREIN (HK2), IN MAMMALIAN-CELLS, The FASEB journal, 10(6), 1996, pp. 2328-2328
EXPRESSION OF HUMAN GLANDULAR KALLIKREIN, HK2, IN CELLS
Authors: KUMAR A GOEL AS HILL TM MIKOLAJCZYK SD MILLAR LS KUUSREICHEL K SAEDI MS
Citation: A. Kumar et al., EXPRESSION OF HUMAN GLANDULAR KALLIKREIN, HK2, IN CELLS, Cancer research, 56(23), 1996, pp. 5397-5402
SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS
Authors: MEYER DL LAW KL PAYNE JK MIKOLAJCZYK SD ZARRINMAYEH H JUNGHEIM LN KING JK SHEPHERD TA STARLING JJ
Citation: Dl. Meyer et al., SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS, Bioconjugate chemistry, 6(4), 1995, pp. 440-446
HIGH-FIELD, SITE-SPECIFIC COUPLING OF N-TERMINALLY MODIFIED BETA-LACTAMASE TO A PROTEOLYTICALLY DERIVED SINGLE-SULFHYDRYL MURINE FAB'
Authors: MIKOLAJCZYK SD MEYER DL STARLING JJ LAW KL ROSE K DUFOUR B OFFORD RE
Citation: Sd. Mikolajczyk et al., HIGH-FIELD, SITE-SPECIFIC COUPLING OF N-TERMINALLY MODIFIED BETA-LACTAMASE TO A PROTEOLYTICALLY DERIVED SINGLE-SULFHYDRYL MURINE FAB', Bioconjugate chemistry, 5(6), 1994, pp. 636-646
SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - REGRESSION AND LONG-TERM GROWTH-INHIBITION OF HUMAN COLON-CARCINOMA XENOGRAFT MODELS
Authors: MEYER DL JUNGHEIM LN LAW KL MIKOLAJCZYK SD SHEPHERD TA MACKENSEN DG BRIGGS SL STARLING JJ
Citation: Dl. Meyer et al., SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - REGRESSION AND LONG-TERM GROWTH-INHIBITION OF HUMAN COLON-CARCINOMA XENOGRAFT MODELS, Cancer research, 53(17), 1993, pp. 3956-3963
Risultati: 1-15 |